Kerri-Ann Millar insider trades
Open-market stock purchases and sales by Kerri-Ann Millar, CHIEF FINANCIAL OFFICER at Cue Biopharma, Inc, from SEC Form 4 filings since Jul 23, 2018.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +232%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- CUE Cue Biopharma, Inc: 1 buy, 1 sale, last Mar 21, 2025